Though these are a normal part of human metabolism, they cause significant oxidative stress over time, damaging DNA inside cells and leading to premature aging
Interestingly, a recent large database study presented at ENDO 2024 suggested that GLP-1s may actually reduce the risk of recurrent pancreatitis in people with obesity and type 2 diabetes compared with some other diabetes drugs
The novel Glp-1/Gip dual receptor agonist Da3-Ch is neuroprotective in the pilocarpine-induced epileptogenesis rat model

Markers community sources associate with a working protocol: Sleep quality improved within the first 1-2 weeks IGF-1 increased 20-40%+ from baseline at 4-6 week bloodwork Gradual improvements in recovery, skin quality, or body composition by weeks 6-8 Mild, transient side effects (slight water retention, occasional joint stiffness) that resolve Patterns community sources describe before discontinuing: No sleep improvement after 2 weeks community sources describe verifying fasted injection timing and peptide source quality IGF-1 unchanged at 4-6 weeks community protocols describe increasing to twice-daily dosing (300 mcg AM + PM) or evaluating peptide authenticity Persistent water retention or joint pain beyond week 3 community sources interpret this as a dose running too high and describe reducing to 200 mcg Signals community and clinical sources associate with stopping: Persistent numbness or tingling in extremities (potential carpal tunnel from excessive GH) Blood glucose consistently elevated on follow-up labs Any signs of abnormal growth or tissue changes documented guidance is to discontinue and consult a physician For detailed protocol parameters, see the ipamorelin dosing guide

But thats a single macro
80 days after that, the Admin will establish a Make Our Children Healthy Again strategy